{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T10:49:08Z","timestamp":1778755748750,"version":"3.51.4"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2015,1,18]],"date-time":"2015-01-18T00:00:00Z","timestamp":1421539200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1007\/s40618-015-0241-7","type":"journal-article","created":{"date-parts":[[2015,1,17]],"date-time":"2015-01-17T02:02:25Z","timestamp":1421460145000},"page":"661-668","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Long-term outcome of Graves\u2019 orbitopathy following high-dose intravenous glucocorticoids and orbital radiotherapy"],"prefix":"10.1007","volume":"38","author":[{"given":"E.","family":"Sisti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Menconi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Leo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. A.","family":"Profilo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Mautone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Mazzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Rocchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Latrofa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Nardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Vitti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Marcocci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Marin\u00f2","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,1,18]]},"reference":[{"key":"241_CR1","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1056\/NEJMcp0806317","volume":"360","author":"L Bartalena","year":"2009","unstructured":"Bartalena L, Tanda ML (2009) Clinical practice. Graves\u2019 orbitopathy. N Engl J Med 360:994\u20131001","journal-title":"N Engl J Med"},{"key":"241_CR2","first-page":"168","volume":"212","author":"L Bartalena","year":"2000","unstructured":"Bartalena L, Pinchera A, Marcocci C (2000) Management of Graves\u2019 ophthalmopathy: reality and perspectives. Endocr Rev 212:168\u2013199","journal-title":"Endocr Rev"},{"key":"241_CR3","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/BF03345280","volume":"27","author":"L Bartalena","year":"2004","unstructured":"Bartalena L, Wiersinga WM, Pinchera A (2004) Graves\u2019 orbitopathy: state of the art and perspectives. J Endocrinol Invest 27:295\u2013301","journal-title":"J Endocrinol Invest"},{"key":"241_CR4","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.beem.2011.11.005","volume":"26","author":"C Marcocci","year":"2012","unstructured":"Marcocci C, Marin\u00f2 M (2012) Treatment of mild, moderate-to-severe and very severe Graves\u2019 orbitopathy. Best Pract Res Clin Endocrinol Metab 26:325\u2013337","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"241_CR5","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/ncpendmet0500","volume":"3","author":"C Marcocci","year":"2007","unstructured":"Marcocci C, Pinchera A, Marin\u00f2 M (2007) A treatment strategy for Graves\u2019 orbitopathy. Nat Clin Pract Endocrinol Metab 3:430\u2013436","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"241_CR6","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1210\/jc.2010-1962","volume":"96","author":"S Zang","year":"2011","unstructured":"Zang S, Ponto KA, Kahaly GJ (2011) Clinical review: intravenous glucocorticoids for Graves\u2019 orbitopathy: efficacy and morbidity. J Clin Endocrinol Metab 96:320\u2013332","journal-title":"J Clin Endocrinol Metab"},{"key":"241_CR7","doi-asserted-by":"crossref","first-page":"3857","DOI":"10.1210\/jc.2012-2758","volume":"97","author":"ML Tanda","year":"2012","unstructured":"Tanda ML, Bartalena L (2012) Efficacy and safety of orbital radiotherapy for graves\u2019 orbitopathy. J Clin Endocrinol Metab 97:3857\u20133865","journal-title":"J Clin Endocrinol Metab"},{"key":"241_CR8","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1007\/s40618-014-0097-2","volume":"37","author":"L Bartalena","year":"2014","unstructured":"Bartalena L, Fatourechi V (2014) Extrathyroidal manifestations of Graves\u2019 disease: a 2014 update. J Endocrinol Invest 37:691\u2013700","journal-title":"J Endocrinol Invest"},{"key":"241_CR9","first-page":"444","volume":"36","author":"E Piantanida","year":"2013","unstructured":"Piantanida E, Tanda ML, Lai A, Sassi L, Bartalena L (2013) Prevalence and natural history of Graves\u2019 orbitopathy in the XXI century. J Endocrinol Invest 36:444\u2013449","journal-title":"J Endocrinol Invest"},{"key":"241_CR10","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1089\/105072504774193276","volume":"14","author":"M Marin\u00f3","year":"2004","unstructured":"Marin\u00f3 M, Morabito E, Brunetto MR, Bartalena L, Pinchera A, Marocci C (2004) Acute and severe liver damage associated with intravenous glucocorticoid pulse therapy in patients with Graves\u2019 ophthalmopathy. Thyroid 14:403\u2013406","journal-title":"Thyroid"},{"key":"241_CR11","doi-asserted-by":"crossref","unstructured":"Sisti E, Coco B, Menconi F, Leo M, Rocchi R, Latrofa F, Profilo MA, Mazzi B, Albano E, Vitti P, Marcocci C, Brunetto M, Marin\u00f2 M (2014) Intravenous glucocorticoid therapy for Graves\u2019 ophthalmopathy and acute liver damage: an epidemiological study. Eur J Endocrinol (in press)","DOI":"10.1530\/EJE-14-0712"},{"key":"241_CR12","doi-asserted-by":"crossref","unstructured":"Marin\u00f2 M, Latrofa F, Menconi F, Chiovato L, Vitti P (2014) An update on the medical treatment of Graves\u2019 hyperthyroidism. J Endocrinol Invest (in press)","DOI":"10.1007\/s40618-014-0136-z"},{"key":"241_CR13","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1046\/j.1365-2265.1997.2331047.x","volume":"47","author":"MP Mourits","year":"1997","unstructured":"Mourits MP, Prummel MF, Wiersinga WM, Koornneef L (1997) Clinical activity score as a guide in the management of patients with Graves\u2019 ophthalmopathy. Clin Endocrinol (Oxf) 47:9\u201314","journal-title":"Clin Endocrinol (Oxf)"},{"key":"241_CR14","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1089\/thy.2007.0315","volume":"18","author":"L Bartalena","year":"2008","unstructured":"Bartalena L, Baldeschi L, Dickinson AJ, Eckstein A, Kendall-Taylor P, Marcocci C, Mourits MP, Perros P, Boboridis K, Boschi A, Curr\u00f2 N, Daumerie C, Kahaly GJ, Krassas G, Lane CM, Lazarus JH, Marin\u00f2 M, Nardi M, Neoh C, Orgiazzi J, Pearce S, Pinchera A, Pitz S, Salvi M, Sivelli P, Stahl M, von Arx G, Wiersinga WM (2008) Consensus statement of the European group on Graves\u2019 orbitopathy (EUGOGO) on management of Graves\u2019 orbitopathy. Thyroid 18:333\u2013346","journal-title":"Thyroid"},{"key":"241_CR15","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1089\/thy.2012.0379","volume":"23","author":"MA Profilo","year":"2013","unstructured":"Profilo MA, Sisti E, Marcocci C, Vitti P, Pinchera A, Nardi M, Rocchi R, Latrofa F, Menconi F, Altea MA, Leo M, Rago T, Marin\u00f2 M (2013) Thyroid volume and severity of Graves\u2019 orbitopathy. Thyroid 23:97\u2013102","journal-title":"Thyroid"},{"key":"241_CR16","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1210\/jc.2006-1800","volume":"92","author":"F Menconi","year":"2007","unstructured":"Menconi F, Marin\u00f2 M, Pinchera A, Rocchi R, Mazzi B, Nardi M, Bartalena L, Marcocci C (2007) Effects of total thyroid ablation versus near-total thyroidectomy alone on mild to moderate Graves\u2019 orbitopathy treated with intravenous glucocorticoids. J Clin Endocrinol Metab 92:1653\u20131658","journal-title":"J Clin Endocrinol Metab"},{"key":"241_CR17","doi-asserted-by":"crossref","first-page":"E44","DOI":"10.1210\/jc.2011-2077","volume":"97","author":"M Leo","year":"2012","unstructured":"Leo M, Marcocci C, Pinchera A, Nardi M, Megna L, Rocchi R, Latrofa F, Altea MA, Mazzi B, Sisti E, Profilo MA, Marin\u00f2 M (2012) Outcome of Graves\u2019 orbitopathy after total thyroid ablation and glucocorticoid treatment: follow-up of a randomized clinical trial. J Clin Endocrinol Metab 97:E44\u2013E48","journal-title":"J Clin Endocrinol Metab"},{"key":"241_CR18","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1210\/jc.2013-3093","volume":"99","author":"M Moleti","year":"2014","unstructured":"Moleti M, Violi MA, Montanini D, Trombetta C, Di Bella B, Sturniolo G, Presti S, Alibrandi A, Campenn\u00ec A, Baldari S, Trimarchi F, Vermiglio F (2014) Radioiodine ablation of postsurgical thyroid remnants after treatment with recombinant human TSH (rhTSH) in patients with moderate-to-severe Graves\u2019 orbitopathy (GO): a prospective, randomized, single-blind clinical trial. J Clin Endocrinol Metab 99:1783\u20131789","journal-title":"J Clin Endocrinol Metab"},{"key":"241_CR19","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1530\/eje.1.02230","volume":"155","author":"WM Wiersinga","year":"2006","unstructured":"Wiersinga WM, Perros P, Kahaly GJ, Mourits MP, Baldeschi L, Boboridis K, Boschi A, Dickinson AJ, Kendall-Taylor P, Krassas GE, Lane CM, Lazarus JH, Marcocci C, Marino M, Nardi M, Neoh C, Orgiazzi J, Pinchera A, Pitz S, Prummel MF, Sartini MS, Stahl M, von Arx G (2006) Clinical assessment of patients with Graves\u2019 orbitopathy: the European Group on Graves\u2019 Orbitopathy recommendations to generalists, specialists and clinical researchers. Eur J Endocrinol 155:387\u2013389","journal-title":"Eur J Endocrinol"},{"key":"241_CR20","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/S0360-3016(01)01699-6","volume":"51","author":"SD Marquez","year":"2001","unstructured":"Marquez SD, Lum BL, McDougall IR, Katkuri S, Levin PS, MacManus M, Donaldson SS (2001) Long-term results of irradiation for patients with progressive Graves\u2019 ophthalmopathy. Int J Radiat Oncol Biol Phys 51:766\u2013774","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"241_CR21","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/S0360-3016(01)01754-0","volume":"52","author":"U Schaefer","year":"2002","unstructured":"Schaefer U, Hesselmann S, Micke O, Schueller P, Bruns F, Palma C, Willich N (2002) A long-term follow-up study after retro-orbital irradiation for Graves\u2019 ophthalmopathy. Int J Radiat Oncol Biol 52:192\u2013197","journal-title":"Int J Radiat Oncol Biol"},{"key":"241_CR22","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1210\/jcem-56-6-1139","volume":"56","author":"L Bartalena","year":"1983","unstructured":"Bartalena L, Marcocci C, Chiovato L, Laddaga M, Lepri G, Andreani D, Cavallacci G, Baschieri L, Pinchera A (1983) Orbital cobalt irradiation combined with systemic corticosteroids for Graves\u2019 ophthalmopathy: comparison with systemic corticosteroids alone. J Clin Endocrinol Metab 56:1139\u20131144","journal-title":"J Clin Endocrinol Metab"},{"key":"241_CR23","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1007\/BF03347943","volume":"14","author":"C Marcocci","year":"1991","unstructured":"Marcocci C, Bartalena L, Bogazzi F, Bruno-Bossio G, Lepri A, Pinchera A (1991) Orbital radiotherapy combined with high dose systemic glucocorticoids for Graves\u2019 ophthalmopathy is more effective than radiotherapy alone: results of a prospective randomized study. J Endocrinol Invest 14:853\u2013860","journal-title":"J Endocrinol Invest"},{"key":"241_CR24","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/0140-6736(93)92001-A","volume":"342","author":"MF Prummel","year":"1993","unstructured":"Prummel MF, Mourits MP, Blank L, Berghout A, Koornneef L, Wiersinga WM (1993) Randomized double-blind trial of prednisone versus radiotherapy in Graves\u2019 ophthalmopathy. Lancet 342:949\u2013954","journal-title":"Lancet"},{"key":"241_CR25","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1530\/EJE-11-0779","volume":"166","author":"C Marcocci","year":"2012","unstructured":"Marcocci C, Watt T, Altea MA, Rasmussen AK, Feldt-Rasmussen U, Orgiazzi J, Bartalena L, European Group of Graves\u2019 Orbitopathy (2012) Fatal and non-fatal adverse events of glucocorticoid therapy for Graves\u2019 orbitopathy: a questionnaire survey among members of the European Thyroid Association. Eur J Endocrinol 166:247\u2013253","journal-title":"Eur J Endocrinol"},{"key":"241_CR26","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1001\/archophthalmol.2011.29","volume":"129","author":"GB Bartley","year":"2011","unstructured":"Bartley GB (2011) Rundle and his curve. Arch Ophthalmol 129:356\u2013358","journal-title":"Arch Ophthalmol"},{"key":"241_CR27","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1089\/thy.1998.8.423","volume":"8","author":"P Perros","year":"1998","unstructured":"Perros P, Kendall-Taylor P (1998) Natural history of thyroid eye disease. Thyroid 8:423\u2013425","journal-title":"Thyroid"},{"key":"241_CR28","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1210\/jc.2012-3873","volume":"98","author":"ML Tanda","year":"2013","unstructured":"Tanda ML, Piantanida E, Liparulo L, Veronesi G, Lai A, Sassi L, Pariani N, Gallo D, Azzolini C, Ferrario M, Bartalena L (2013) Prevalence and natural history of Graves\u2019 orbitopathy in a large series of patients with newly diagnosed Graves\u2019 hyperthyroidism seen at a single center. J Clin Endocrinol Metab 98:1443\u20131449","journal-title":"J Clin Endocrinol Metab"},{"key":"241_CR29","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1089\/thy.2013.0240","volume":"24","author":"F Menconi","year":"2014","unstructured":"Menconi F, Profilo MA, Leo M, Sisti E, Altea MA, Rocchi R, Latrofa F, Nardi M, Vitti P, Marcocci C, Marin\u00f2 M (2014) Spontaneous improvement of untreated mild Graves\u2019 ophthalmopathy: Rundle\u2019s curve revisited. Thyroid 24:60\u201366","journal-title":"Thyroid"},{"issue":"Suppl 2","key":"241_CR30","first-page":"198","volume":"7","author":"A Eckstein","year":"2010","unstructured":"Eckstein A, Esser J, Mann K, Schott M (2010) Clinical value of TSH receptor antibodies measurement in patients with Graves\u2019 orbitopathy. Pediatr Endocrinol Rev 7(Suppl 2):198\u2013203","journal-title":"Pediatr Endocrinol Rev"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-015-0241-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40618-015-0241-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-015-0241-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,19]],"date-time":"2019-08-19T16:17:24Z","timestamp":1566231444000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40618-015-0241-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1,18]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["241"],"URL":"https:\/\/doi.org\/10.1007\/s40618-015-0241-7","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,1,18]]}}}